ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,187.46
0.28%
Dow Jones
41,198.08
0.59%
Gold vs US Dollar
2,460.685
-0.32%
Brent Oil
84.485
1.40%
Bitcoin
64,261.87
-1.27%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Sanofi (SNW) Share Price

SNW Sanofi

91.82
-0.10 (-0.11%)
17 Jul 2024 - Closed
Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Sanofi TG:SNW Tradegate (DE) Ordinary Share FR0000120578 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   -0.10 -0.11 91.82 91.70 91.94 92.26 90.76 92.01 2,898 21:50:06   
 Type  Size  Price  Time  Units 
  2 91.74 19:23:33 EUR
 
Recent News
DateTimeSource
HeadlineMore SNW News
17/07/202422:27UKREGPress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
17/07/202422:27UKREGCommuniqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère
03/07/202406:00GLOBECommuniqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne
03/07/202406:00GLOBEPress Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
26/06/202422:30GLOBECommuniqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans
26/06/202422:30GLOBEPress Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
25/06/202418:32GLOBECommuniqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 »
Period
Draw mode
Data Downloads for SNW

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Sanofi Articles